Artimplant appoints Lars-Johan Cederbrant as Chief financial Officer

Artimplant, the Swedish biomaterials company, appoints Lars-Johan Cederbrant as Chief Financial Officer.

Mr. Cederbrant will assume his new responsibility during August 2005. Lars-Johan Cederbrant has previously served as CEO of CardioBridge GmbH and as CFO during the reconstruction of Jomed N.V. “His experience from the medical technology industry and from business development helps to strengthen the Company as we expand on our biomaterial platform Artelon®”, states CEO Tord Lendau. For additional information, please contact: Tord Lendau, CEO, phone +46 (0)31 746 56 00, +46 (0)708 369 403, tord.lendau@artimplant.se Web site: www.artimplant.com